ANKRD18DP: A Potential Drug Target and Biomarker (G348840)

Target Name: ANKRD18DP

NCBI ID: G348840

ANKRD18DP

Other Name(s): Ankyrin repeat domain 18D, pseudogene | ankyrin repeat domain 18D, pseudogene

ANKRD18DP: A Potential Drug Target and Biomarker

Ankyrin repeat domains (ARDs) are a class of gene duplicates that have been identified in many genomes as having potential roles in various biological processes. One such domain is the ANKRD18DP gene, which has been identified in the human genome and has been shown to play a role in several cellular processes. In this article, we will explore the ANKRD18DP gene and its potential as a drug target and biomarker.

Overview of ANKRD18DP

The ANKRD18DP gene is located on chromosome 18q21 and has a length of 1,274 base pairs. It is a member of the ANKRD gene family, which is characterized by the presence of ankyrin repeats in the protein coding region. ANKRD genes are known to have diverse functions in various cellular processes, including intracellular signaling, protein-protein interactions, and cell signaling pathways.

The ANKRD18DP gene was first identified in the 1990s using PCR-based amplification of the genomic DNA. Since then, several studies have demonstrated that ANKRD18DP is expressed in various tissues and cells, including brain, heart, liver, and pancreas. The gene has also been shown to be involved in several cellular processes, including cell signaling, cell adhesion, and chromatin regulation.

Potential Drug Target

The ANKRD18DP gene has been shown to play a role in several cellular processes that are relevant to drug development. One of the most promising aspects of ANKRD18DP is its potential as a drug target. The ANKRD18DP gene has been shown to be involved in several signaling pathways that are relevant to several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

For example, ANKRD18DP has been shown to be involved in the regulation of the Notch signaling pathway, which is a critical pathway involved in cell signaling and development. Notch signaling is a highly conserved signaling pathway that is involved in the regulation of stem cells, tissue regeneration, and immune responses. ANKRD18DP has been shown to play a role in the regulation of Notch signaling by modulating the activity of several transcription factors, including Notch1 and Notch2.

In addition to its role in the Notch signaling pathway, ANKRD18DP has also been shown to be involved in the regulation of several other signaling pathways, including the TGF-β pathway and the Wnt pathway. TGF-β is a signaling pathway involved in cell signaling and growth, while Wnt is a signaling pathway involved in the regulation of cell adhesion and differentiation.

Potential Biomarker

The ANKRD18DP gene has also been shown to be involved in the regulation of several biomarkers that are relevant to drug development. For example, ANKRD18DP has been shown to be involved in the regulation of brain-derived neurotrophic factor (BDNF), a protein that is involved in the regulation of brain function and is often used as a biomarker for the diagnosis and treatment of neurodegenerative diseases.

In addition to its role in the regulation of BDNF, ANKRD18DP has also been shown to be involved in the regulation of several other biomarkers, including GFAP, a protein that is involved in the regulation of cell signaling and is often used as a biomarker for the diagnosis and treatment of guitar cell carcinoma.

Conclusion

In conclusion, ANKRD18DP is a gene that has been identified in the human genome and has been shown to play a role in several cellular processes. Its potential as a drug target and biomarker make it an attractive target for further research and development. Further studies are needed to fully understand the functions of ANKRD18DP and its potential as a drug

Protein Name: Ankyrin Repeat Domain 18D, Pseudogene

The "ANKRD18DP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD18DP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets